Blunted cGMP response to agonists and enhanced glomerular cyclic 3′,5′-nucleotide phosphodiesterase activities in experimental congestive heart failure-Reference-Cited by-同舟云学术

Blunted cGMP response to agonists and enhanced glomerular cyclic 3′,5′-nucleotide phosphodiesterase activities in experimental congestive heart failure

Published:1996-11 Issue:5 Volume:50 Page:1718-1725
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Supaporn Thanom,Sandberg Sharon M.,Borgeson Daniel D.,Heublein Denise M.,Luchner Andreas,Wei Chi-Ming,Dousa Thomas P.,Burnett John C.

Publisher

Elsevier BV

Subject

Nephrology

Reference55 articles.

1. The biochemical pharmacology of atrial peptides;Needleman;Annu Rev Pharmacol Toxicol,1989

2. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide;Okawa;Circ Res,1991

3. Immunohistochemical localization of C-type natriuretic peptide in human vascular endothelial cells;Heublein;J Vase Res,1992

4. Presence of C-type natriuretic peptide in human kidney and urine;Mattingly;Kidney Int,1994

5. Natriuretic peptide in human heart failure;Wei;Circulation,1993

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlates of Plasma NT‐proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial;Journal of the American Heart Association;2024-04-02

2. Combined Inhibition of Phosphodiesterase-5 and -9 in Experimental Heart Failure;JACC: Heart Failure;2024-01

3. Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure;International Journal of Molecular Sciences;2023-07-14

4. Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms;International Journal of Molecular Sciences;2023-03-07

5. Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial;Circulation: Heart Failure;2023-01-25